125 related articles for article (PubMed ID: 12101203)
1. Detection of the CD56+/CD45- immunophenotype by flow cytometry in neuroendocrine malignancies.
Bryson GJ; Lear D; Williamson R; Wong RC
J Clin Pathol; 2002 Jul; 55(7):535-7. PubMed ID: 12101203
[TBL] [Abstract][Full Text] [Related]
2. CD56 expression of neuroendocrine neoplasms on immunophenotyping by flow cytometry: a novel diagnostic approach to fine-needle aspiration biopsy.
Farinola MA; Weir EG; Ali SZ
Cancer; 2003 Aug; 99(4):240-6. PubMed ID: 12925986
[TBL] [Abstract][Full Text] [Related]
3. Detection of Nonhematologic Neoplasms by Routine Flow Cytometry Analysis.
Annunziata J; Miller ML; Park DC; Vlad G; Bhagat G; Alobeid B
Am J Clin Pathol; 2020 Jan; 153(1):99-104. PubMed ID: 31587038
[TBL] [Abstract][Full Text] [Related]
4. Interference of bone marrow CD56
Theodorakos I; Paterakis G; Papadakis V; Vicha A; Topakas G; Jencova P; Karchilaki E; Taparkou A; Tsagarakis NJ; Polychronopoulou S
Pediatr Blood Cancer; 2019 Aug; 66(8):e27799. PubMed ID: 31066205
[TBL] [Abstract][Full Text] [Related]
5. A new sensitive and specific combination of CD81/CD56/CD45 monoclonal antibodies for detecting circulating neuroblastoma cells in peripheral blood using flow cytometry.
Nagai J; Ishida Y; Koga N; Tanaka Y; Ohnuma K; Toyoda Y; Katoh A; Hayabuchi Y; Kigasawa H
J Pediatr Hematol Oncol; 2000; 22(1):20-6. PubMed ID: 10695817
[TBL] [Abstract][Full Text] [Related]
6. Detecting CD56+/NB84+/CD45- immunophenotype in the bone marrow of patients with metastatic neuroblastoma using flow cytometry.
Bozzi F; Gambirasio F; Luksch R; Collini P; Brando B; Fossati-Bellani F
Anticancer Res; 2006; 26(5A):3281-7. PubMed ID: 17094441
[TBL] [Abstract][Full Text] [Related]
7. The potential role of flow cytometry in the diagnosis of small cell carcinoma.
Cornfield D; Liu Z; Gorczyca W; Weisberger J
Arch Pathol Lab Med; 2003 Apr; 127(4):461-4. PubMed ID: 12683875
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical Analysis of Scarring Trachoma Indicates Infiltration by Natural Killer and Undefined CD45 Negative Cells.
Hu VH; Luthert PJ; Derrick T; Pullin J; Weiss HA; Massae P; Mtuy T; Makupa W; Essex D; Mabey DC; Bailey RL; Holland MJ; Burton MJ
PLoS Negl Trop Dis; 2016 May; 10(5):e0004734. PubMed ID: 27219121
[TBL] [Abstract][Full Text] [Related]
9. Detection of the GD2+/CD56+/CD45- immunophenotype by flow cytometry in cerebrospinal fluids from a patient with retinoblastoma.
Shen H; Tang Y; Xu X; Tang H
Pediatr Hematol Oncol; 2013 Feb; 30(1):30-2. PubMed ID: 23126274
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric immunophenotyping test for staging/monitoring neuroblastoma patients.
Warzynski MJ; Graham DM; Axtell RA; Higgins JV; Hammers YA
Cytometry; 2002 Dec; 50(6):298-304. PubMed ID: 12497591
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometry identification of nonhemopoietic neoplasms during routine immunophenotyping.
Stacchini A; Aliberti S; Demurtas A; Maletta F; Molinaro L; Godio L; Papotti M
Int J Lab Hematol; 2019 Apr; 41(2):208-217. PubMed ID: 30480372
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric detection of small cell lung cancer cells with aberrant CD45 expression in micrometastatic bone marrow.
Danbara M; Yoshida M; Kanoh Y; Jiang SX; Masuda N; Akahoshi T; Higashihara M
Jpn J Clin Oncol; 2009 Nov; 39(11):771-5. PubMed ID: 19674995
[TBL] [Abstract][Full Text] [Related]
14. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
McCluggage WG; Kennedy K; Busam KJ
Am J Surg Pathol; 2010 Apr; 34(4):525-32. PubMed ID: 20182342
[TBL] [Abstract][Full Text] [Related]
15. Immunophenotypic analysis of abnormal plasma cell clones in bone marrow of primary systemic light chain amyloidosis patients.
Hu Y; Wang M; Chen Y; Chen X; Fang F; Liu S; Zhang Y; Wu X; Zhu P
Chin Med J (Engl); 2014; 127(15):2765-70. PubMed ID: 25146610
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric analysis of peripheral blood and bone marrow for tumor cells in patients with neuroblastoma.
Komada Y; Zhang XL; Zhou YW; Inaba H; Deguchi T; Azuma E; Sakurai M
Cancer; 1998 Feb; 82(3):591-9. PubMed ID: 9452279
[TBL] [Abstract][Full Text] [Related]
17. Utility of the quantitative Ki-67 proliferation index and CD56 together in the cytologic diagnosis of small cell lung carcinoma and other lung neuroendocrine tumors.
Zheng G; Ettinger DS; Maleki Z
Acta Cytol; 2013; 57(3):281-90. PubMed ID: 23635388
[TBL] [Abstract][Full Text] [Related]
18. Classical and atypical neuroblastoma--case reports.
Csáthy L; Kappelmayer J; Szegedi I; Kajtár B; Kiss C; Hevessy Z
Cytometry B Clin Cytom; 2011 Mar; 80(2):134-6. PubMed ID: 21337495
[TBL] [Abstract][Full Text] [Related]
19. Interferon-γ production by tubulointerstitial human CD56
Law BMP; Wilkinson R; Wang X; Kildey K; Lindner M; Rist MJ; Beagley K; Healy H; Kassianos AJ
Kidney Int; 2017 Jul; 92(1):79-88. PubMed ID: 28396119
[TBL] [Abstract][Full Text] [Related]
20. Detection of micrometastasis of neuroblastoma to bone marrow and tumor dissemination to hematopoietic autografts using flow cytometry and reverse transcriptase-polymerase chain reaction.
Tsang KS; Li CK; Tsoi WC; Leung Y; Shing MM; Chik KW; Lee V; Ng MH; Yuen P
Cancer; 2003 Jun; 97(11):2887-97. PubMed ID: 12767104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
